abstract |
The disclosure relates to compounds having general formula (I), wherein: R1 represents H or an alkyl, cycloalkyl, cycloalkylalkyl, phenylalkyl, alkenyl, alkynyl group; R2 represents a pyridinyl, furanyl, thienyl, thiazolyl or oxazolyl group, said group being optionally substituted; and R3 represents H, one or more substituents selected from among the halogen atoms and the trifluoromethyl, alkyl, cycloalkyl, alkoxy, phenyl, cyano, acetyl, benzoyl, thioalkyl, alkylsulfonyl, carboxy or alcoxycarbonyl groups, or a group having general formula NR4R5 or SO2NR4R5 or CONR4R5 in which R4 and R5 each represent H or an alkyl group or, together with the nitrogen atom bearing same, form a pyrrolidine, piperidine or morpholine ring, said compound taking the form of a base, an acid addition salt, a hydrate or a solvate. The disclosure also relates to the use of the compound in therapeutics. |